NasdaqCM - Nasdaq Real Time Price USD
MiMedx Group, Inc. (MDXG)
At close: November 7 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
50,840.00
26,775.00
-17,893.00
-1,982.00
-30,263.00
Investing Cash Flow
-8,059.00
-2,155.00
-2,660.00
-3,395.00
-4,555.00
Financing Cash Flow
-42,396.00
-8,570.00
-580.00
-3,352.00
61,561.00
End Cash Position
69,037.00
82,000.00
65,950.00
87,083.00
95,812.00
Income Tax Paid Supplemental Data
--
--
181.00
169.00
208.00
Interest Paid Supplemental Data
4,927.00
6,034.00
4,569.00
4,327.00
7,456.00
Capital Expenditure
-7,670.00
-1,987.00
-2,514.00
-3,218.00
-4,228.00
Issuance of Capital Stock
--
--
--
--
100,000.00
Issuance of Debt
--
--
--
--
59,500.00
Repayment of Debt
-81,049.00
-52.00
-41.00
-38.00
-85,311.00
Repurchase of Capital Stock
-12,016.00
-9,515.00
-1,190.00
-4,751.00
-2,334.00
Free Cash Flow
43,170.00
24,788.00
-20,407.00
-5,200.00
-34,491.00
12/31/2020 - 2/12/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTE Aerovate Therapeutics, Inc.
2.7400
-0.72%
NGNE Neurogene Inc.
69.50
+8.75%
SRZN Surrozen, Inc.
10.19
-1.83%
IRON Disc Medicine, Inc.
63.33
-2.27%
VIR Vir Biotechnology, Inc.
9.77
-3.93%
ARTV Artiva Biotherapeutics, Inc.
13.96
-3.52%
ZNTL Zentalis Pharmaceuticals, Inc.
3.8100
-0.78%
CORT Corcept Therapeutics Incorporated
54.30
+0.13%
KALV KalVista Pharmaceuticals, Inc.
11.18
-2.02%
GANX Gain Therapeutics, Inc.
2.2300
-1.76%